Doctor explaining test results photo
Minneapolis Heart Institute Logo Doctor explaining test results photo geometric wall pattern entrance photo
Home MHI Physicians Information for Patients Programs Information for Physicians Publications About MHI

Hypertropic Cardiomyopathy Center of the Minneapolis Heart Institute: Established for the management and diagnosis of Hypertropic Cardiomyopathy

By: Barry J. Maron, MD

Significance of Hypertrophic Cardiomyopathy

  • Is the most common genetic cardiovascular disease
  • Is the most common cause of sudden death in the young and in athletes
  • May affect patients of any age
  • Is frequently unrecognized clinically in many patients
  • Is an important cause of cardiovascular disability including heart failure, atrial fibrillation and stroke

All things considered, HCM, ironically may be of little or no clinical significance, and compatible with normal longevity.

Definition of Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM) is a genetic disease affecting the heart muscle. The most consistent feature of HCM is excessive thickening of the wall of the heart muscle (hypertrophy = heart muscle thickening; cardiomyopathy = diseased heart muscle). The consequences of HCM to patients are related, in part or solely, to the abnormally thickened heart muscle, which in turn is a consequence of the basic genetic defect. Hypertrophy may be widespread throughout the left ventricle, though not necessarily, and there is no single “typical” pattern of muscle thickening.

The heart (specifically the left ventricle) may also thicken in other individuals who do not have HCM, either as a result of high blood pressure, obstructive heart valve disease, or even prolonged and intense athletic training in certain sports. The type of hypertrophy associated with high blood pressure is often referred to as “secondary” (i.e., a secondary consequence of the increased blood pressure). In HCM, however, the muscular thickening of the heart wall is primary, i.e., due to a genetic defect and not a reaction to other factors. In addition, when the heart muscle of HCM is viewed under a light microscope, it usually shows several particular abnormalities, the most prominent of which is called myocardial cell (myocyte) disarray or disorganization , in which normal parallel alignment of heart muscle cells has been lost and many of the muscle cells are arranged in a characteristically chaotic and disorganized pattern. It is likely that this cell disarray interferes with normal electrical transmission of impulses and predisposes some patients to irregularities of heart rhythm, as well as altering the heart contraction.

The cell structure and architecture of the HCM heart. Diagrams contrast the regular and parallel alignment of muscle cells in the normal heart (top) with the irregular, disorganized alignment of cells ("myocardial disarray") found in some areas of the HCM heart (middle). Above (bottom) is a picture of an actual area of an HCM heart (from a histologic section) showing a disorganized chaotic arrangement of cardiac muscle cells (myocytes). 

The Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute
Although a relatively common genetic cardiovascular disease, Hypertrophic Cardiomyopathy is uncommon in cardiology practice. The major goals of the Hypertrophic Cardiomyopathy Center are to offer patient and family education and genetic counseling regarding HCM, and to assess patients to determine clinical course of action, prognosis and treatment options. There are a number of potential therapies available to the HCM patient. The Hypertrophic Cardiomyopathy Center can provide recommendations regarding the optimal therapy to relieve or reduce symptoms, including drugs, interventional options such as surgery, pacemaker implantation or alcohol septal ablation.

The Minneapolis Heart Institute Foundation (MHIF) Hypertrophic Cardiomyopathy Center is designed to provide patients with a state-of-the-art evaluation. The Center is staffed by nationally recognized cardiologists with a subspecialty expertise in the evaluation and treatment of patients with hypertrophic cardiomyopathy. The Hypertrophic Cardiomyopathy Center is supervised by Dr. Barry Maron, who has been involved extensively with HCM for almost 30 years.

Health Care Professionals and Patients:
More information on Hypertrophic Cardiomyopathy

 

Quick Finder
Scheduling an Appointment
Learn how to make an appointment at MHI™.

Make An Appointment - Learn More